HPV Vaccination Initiative in India

On February 28, India launched a nationwide Human Papillomavirus (HPV) vaccination program targeting adolescent girls. This is a significant public health measure aimed at eliminating cervical cancer, which remains a leading cause of death among women despite being preventable.

Global and National Context

• Cervical Cancer Statistics:
  • Globally, it is the fourth most common cancer among women with approximately 660,000 new cases and 350,000 deaths annually.
  • In India, cervical cancer ranks as the second most common cancer among women and the third most common overall, with over 78,000 new cases and nearly 43,000 deaths each year.
• Causes and Risk Factors:
  • Primarily caused by HPV infection of the genital tract.
  • Risk factors include early marriage, early sexual activity, multiple pregnancies, tobacco use, and poor genital hygiene.

WHO's Global Elimination Strategy

• First cancer declared by WHO for global elimination.
• Elimination Target: Fewer than 4 new cases per 100,000 women per year.
• "90–70–90" Strategy:
  • 90% of girls fully vaccinated with HPV vaccine by age 15.
  • 70% of women screened with a high-performance test at ages 30 and above.
  • 90% of women with disease to receive appropriate treatment.

HPV Vaccine Safety and Effectiveness

• HPV vaccines have a robust global safety record with mainly mild side effects such as pain, redness, or swelling at the injection site.
• Over 140 countries have implemented HPV vaccination programs.
• Studies show a single dose provides long-term protection with supportive data from Tata Memorial Centre.

Challenges and Opportunities

• Cervical cancer rates are declining globally due to better awareness, screening, and vaccination, but progress is uneven across regions.
• Urban areas in India show some decline in rates, whereas rural areas still present advanced cases.
• Sustained vaccination coverage is crucial to prevent a resurgence in cervical cancer cases.

Conclusion

India's introduction of the HPV vaccination is scientifically sound, cost-effective, and ethically imperative. Alongside enhanced screening and treatment access, this initiative is expected to significantly reduce cervical cancer incidence, benefiting future generations.